BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
DNA fingerprint
,
Doxycycline
,
rs6983267
,
PRKCA
,
glucose metabolic process
,
Leukemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
mogamulizumab
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Long-term safety and efficacy of mogamulizumab (anti-CCR4) for treating virus-associated myelopathy.
Clinical and Real-World Effectiveness of Mogamulizumab: A Narrative Review.
Cost-utility analysis of mogamulizumab in advanced mycosis fungoides and Sézary syndrome cutaneous T…
Effectiveness of mogamulizumab in patients with Mycosis Fungoides or Sézary syndrome: A multicentre,…
Overall survival in the UK in mycosis fungoides or Sézary syndrome cutaneous T-cell lymphoma: compar…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Mogamulizumab and Pembrolizumab in Treating Patients With Relapsed or Refractory Diffuse Large B Cel…
Phase Ia/Ib Multicenter Trial of Mogamulizumab for Advanced or Recurrent Cancer.
Study of Mogamulizumab + Nivolumab in Subjects w/Locally Advanced or Metastatic Solid Tumors
Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome
Study of Mogamulizumab + MEDI4736 (Durvalumab) and Mogamulizumab + Tremelimumab in Subjects w/ Advan…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ